ASHLEY MELLOTT: Open Payments
NPI 1053084731 · EVANSVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$956 in 56 payments from 20 companies in 2025. Trend: 2023 $1,307 · 2024 $951 · 2025 $956
Food & beverage: $956
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $195 |
| AstraZeneca Pharmaceuticals LP | 3 | $149 |
| Otsuka America Pharmaceutical, Inc. | 5 | $114 |
| Novo Nordisk Inc | 5 | $76 |
| PFIZER INC. | 4 | $75 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $48 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $44 |
| Axsome Therapeutics, Inc. | 3 | $43 |
| Kowa Pharmaceuticals America, Inc. | 2 | $35 |
| Vanda Pharmaceuticals Inc. | 1 | $20 |
Products named: AIRSUPRA, REXULTI, QULIPTA, UBRELVY, NURTEC ODT, JARDIANCE, Ozempic, CAPLYTA.
Industry payments across IN — which companies pay providers there.
